Generics and the Canadian European Trade Agreement What will Canada’s new trade agreement with Europe, CETA, mean for the country’s generics industry. Tom Norton, a veteran of America’s ‘Great Generic Wars’ is watching with interest. Read more
More DAAs, More Controversy The storms raging across Europe—and beyond—over the pricing of new hepatitis C treatments have been intensified by the European Union's approval last week of the latest directly-acting antiviral, Bristol-Myers Squibb's Daklinza (daclatasvir). Peter O’Donnell reports... Read more
Read the New Pharm Exec Global Digest: Technology Special In this month’s issue: UBISTART, the US-French payout initiative for new startups; Fixing the Medical Technology Disconnect; the Future of Safety Signal Detection and Risk Management; Wearable Healthcare Technology ... Read more
Pharm Exec’s Emerging Pharma Leaders 2014 This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise — all binded by an underlying commitment to the patient.... Read more
